Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis
Article in Cellular Oncology (February 2024)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Article in Cellular Oncology (February 2024)
Article in Computers in Biology and Medicine (November 2023)
Preprint in Research Square (October 2023)